Defense Health Agency Contracting Activity - DHACA

Description

The FY19 MRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in melanoma research. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active duty Service members, Veterans, other military beneficiaries, and the American public. The Idea Award is not intended to support a logical progression of an already established research project. The proposed research should be innovative. A key characteristic of this funding opportunity is innovation. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Incremental advances, the next logical step, or switching a model system from one cancer to another cancer is not considered innovative. The proposed research project should include a well-formulated, testable novel hypothesis based on strong scientific rationale and study design. The FY19 MRP is not requesting research into established macrometastatic disease, models of metastatic disease using established cell lines, or treatment of macrometastatic disease. Studies involving non-melanoma skin cancers are not allowed under the FY19 MRP.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org